ATE412748T1 - Zusammensetzungen und verfahren zur induktion einer antitumorimmunität - Google Patents

Zusammensetzungen und verfahren zur induktion einer antitumorimmunität

Info

Publication number
ATE412748T1
ATE412748T1 AT05744134T AT05744134T ATE412748T1 AT E412748 T1 ATE412748 T1 AT E412748T1 AT 05744134 T AT05744134 T AT 05744134T AT 05744134 T AT05744134 T AT 05744134T AT E412748 T1 ATE412748 T1 AT E412748T1
Authority
AT
Austria
Prior art keywords
compositions
methods
cell surface
antibody
antitumor immunity
Prior art date
Application number
AT05744134T
Other languages
English (en)
Inventor
Karl Erik Hellstrom
Ingegerd Hellstrom
Yi Yang
Original Assignee
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington Res Found filed Critical Washington Res Found
Application granted granted Critical
Publication of ATE412748T1 publication Critical patent/ATE412748T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05744134T 2004-03-26 2005-03-25 Zusammensetzungen und verfahren zur induktion einer antitumorimmunität ATE412748T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55663304P 2004-03-26 2004-03-26

Publications (1)

Publication Number Publication Date
ATE412748T1 true ATE412748T1 (de) 2008-11-15

Family

ID=34968387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05744134T ATE412748T1 (de) 2004-03-26 2005-03-25 Zusammensetzungen und verfahren zur induktion einer antitumorimmunität

Country Status (6)

Country Link
US (1) US20070286860A1 (de)
EP (1) EP1737958B1 (de)
AT (1) ATE412748T1 (de)
CA (1) CA2560937A1 (de)
DE (1) DE602005010680D1 (de)
WO (1) WO2005097997A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507565A (ja) 2008-10-30 2012-03-29 グオ・ペイシュエン Ｄｎａのシークエンシング及び他の用途のための、膜に組み込まれたウイルスｄｎａパッケージングモータタンパク質コネクタバイオセンサ
CN109970865B (zh) * 2017-12-28 2022-10-04 上海细胞治疗研究院 一种cd137双向激活共刺激分子受体及其用途
CN110856724B (zh) * 2018-08-24 2022-05-27 杭州康万达医药科技有限公司 包含核酸及car修饰的免疫细胞的治疗剂及其应用
CN110893236A (zh) * 2019-10-09 2020-03-20 中山大学 溶酶体靶向的抗体药物偶联物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219436A1 (en) * 2002-03-15 2003-11-27 Ledbetter Jeffrey A. Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein

Also Published As

Publication number Publication date
US20070286860A1 (en) 2007-12-13
EP1737958B1 (de) 2008-10-29
CA2560937A1 (en) 2005-10-20
DE602005010680D1 (de) 2008-12-11
WO2005097997A1 (en) 2005-10-20
EP1737958A1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
WO2017147383A8 (en) Modified cells for immunotherapy
MX2021004660A (es) Moleculas de union multivalentes a base de igm- e iga-fc.
CY1121132T1 (el) ΠΛΗΡΩΣ-ΑΝΘΡΩΠΙΝΑ ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ANTI-vap-1
CY1122435T1 (el) Ποντικοι με εξανθρωπισμενη καθολικη ελαφρια αλυσιδα
WO2020069184A3 (en) Compositions and methods for treating cancer with anti-cd19/cd22 immunotherapy
MY162752A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
MX2019001184A (es) Anticuerpos anti-idiotípicos y métodos relacionados.
PH12017500596A1 (en) Car expression vector and car-expressing t cells
MX337456B (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores.
EP4279086A3 (de) Zusammensetzungen und verfahren zur behandlung von krebs mit anti-cd19-immuntherapie
WO2005016967A3 (en) Modified human igf-1r antibodies
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
PH12018501473A1 (en) Chimeric antigen receptors targeting epidermal growth factor receptor variant iii
EP4653456A3 (de) Chimäre antigenrezeptoren zur anzielung des b-zellen-reifungsantigens
WO2015069922A3 (en) Alk antibodies, conjugates, and chimeric antigen receptors, and their use
MX2011012047A (es) Inmunoglobulinas humanas anti-cd52.
MX361929B (es) Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.
WO2000029582A3 (en) Cell surface receptor antigen vaccines
CL2011000632A1 (es) Anticuerpo humanizado anti-receptor de interleuquina 6 (il-6); regiones variables y cadenas pesadas o livianas de los mismos; secuencia nucleotídica que lo codifica; vector; célula huésped; método de producción; y composición farmacéutica que lo comprende.
CY1113713T1 (el) Ανοσοκατασταλτικα πολυπεπτιδια και νουκλεϊκα οξεα
CY1118797T1 (el) Ανταγωνιστες toll-ωδους υποδοχεα 3
MX340315B (es) Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos.
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
UA95329C2 (ru) Собачий тимусный стромальный лимфопоэтин и его применение
EP3806910A4 (de) Tumorinfiltrierende chimäre antigenrezeptor-lymphozyten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties